A literature review published in JAMA Internal Medicine finds that many medical tests are overused and overtreatment is common and potentially harmful.
Endocrinology Network Editorial Staff
A 58-year-old man with a history of diabetes mellitus type 1 went to the urgent care after he awoke one morning and noticed the bottom of his foot near his toes felt funny. When he looked at the area, he realized that a bulla had formed on the bottom of his foot overnight. He hadn’t injured or cut the foot or leg recently, and he felt in good health otherwise. What's your diagnosis?
Researchers writing in the New England Journal of Medicine report that a combination treatment of ticagrelor and aspirin leads to improved cardiovascular disease outcomes in patients with stable coronary artery disease and diabetes mellitus.
The cost of treating osteoporosis in the United states has risen 118 percent over the last 19 years, shows an analysis presented this week at the American Society for Bone and Mineral Research annual meeting in Orlando.
A 60-year-old woman undergoing hemodialysis for chronic kidney disease visited her physician with concerns about a painful smooth plaque on her leg that developed over the last few weeks. What's your diagnosis?
Metformin as monotherapy is the preferred treatment for children and teens with type 2 diabetes, but a new study published in the Aug. 15 issue of the New England Journal of Medicine suggests that adding liraglutide to the treatment can more effectively control glycemic levels.
A single course of treatment with teplizumab significantly slowed the progression of type 1 diabetes in high-risk individuals who had not yet deveoped the condition, according to a study in the New England Journal of Medicine.
The parents of a 7-month-old girl brought their daughter to the ED after noticing that her skin was peeling all over her body. She also had diarrhea. What's your diagnosis?
Obesity was classified as a disease by the American Medical Association in 2013, but in the United Kingdom, experts are still grappling with whether they should follow suit. In this slideshow, we highlight positions on the issue.
Patients who are at high-risk of developing type 1 diabetes may be able to delay the progression of the condition with teplizumab treatment, a new study shows.